Today we are looking at Cassava Sciences, Inc. (NASDAQ: SAVA), to determine if you should buy SAVA stock. We will look at SAVA financial ratios, analyst ratings, and current valuation to determine a SAVA forecast and price. What Does SAVA Do? Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer’s disease. The company was formerly known…